Compassionate Care Application - Spanish

CEoT 2024 Flyer

ISHLT 2024 Flyer

Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease States

Halloran, et al. Transplantation 2023

Natera Product Brochure

Why Cell‐Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection

Rosenheck JP, Keller BC, Fehringer G, et al. Curr Pulmonol Rep. 2022

Letter to the Editors: Performance of Donor-derived Cell-free DNA Assays in Kidney Transplant Patients

Altug Y, Demko ZP, Ryan A. Letter to the Editors - Transplantation. 2020

Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection

Bunnapradist S, Homkrailas P, Ahmed E, et al. J Am Soc Nephrol 2021

Single center experience comparing two clinically available donor derived cell free DNA tests and review of literature

Lum EL, Nieves-Borrero K, Homkrailas P, et al. Transplantation Reports. 2021

Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management

Qazi Y, Patel A, Fajardo M, et al. Transplant Proc. 2021

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplanta

Ventura-Aguiar P, Ramirez-Bajo MJ, Rovira J, et al. Transplantation. 2022

The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies

Halloran PF, Reeve J, Madill-Thomsen KS, et al. J Am Soc Nephrol.

Real-world Clinical Experience Implementing Donor-derived Cell- free DNA for Detection of Acute Lung Allograft Dysfunction after Lung Trans

Girgis R, Lawson C, Bhorade S, et al. Mar Pulmonology and Respiratory Medicine (2023)

Prospera Patient Discussion Guide